Residency · Residency · Medicine Pediatrics
Down Syndrome: Lifespan Health Supervision
Introduction
Down syndrome (trisomy 21) is the most common chromosomal condition, occurring in approximately 1 in 700 live births. Advances in medical and surgical care have dramatically increased life expectancy, with the median now exceeding 60 years. Med-peds physicians play a critical role in providing comprehensive, guideline-directed health supervision from infancy through adulthood, addressing the unique medical comorbidities that evolve across the lifespan.
Genetics and Diagnosis
Full trisomy 21 accounts for ~95% of cases, resulting from meiotic nondisjunction. Translocation trisomy 21 (~3-4%) involves attachment of chromosome 21 material to another chromosome; may be inherited. Mosaicism (~1-2%) results in variable phenotype depending on percentage of trisomic cells. Prenatal screening includes cell-free DNA (cfDNA) testing, first-trimester combined screening, and quad screen. Diagnosis is confirmed by karyotype or chromosomal microarray. Genetic counseling should be offered to all families, including recurrence risk assessment.
Health Supervision in Infancy and Childhood
| System | Condition | Prevalence | Screening Recommendation |
|---|---|---|---|
| Cardiac | CHD (esp. AVSD) | 40-50% | Echo in all newborns |
| Endocrine | Hypothyroidism | 15-20% | TSH at birth, 6mo, 12mo, then annually |
| Endocrine | Celiac disease | 5-12% | tTG-IgA starting at age 2 |
| Hematologic | TAM/leukemia risk | 10% TAM; 20-30% progress to AMKL | CBC monitoring first 3 years |
| Hearing | Conductive/sensorineural loss | Up to 75% | Audiogram by 6 months, then annually |
| Vision | Strabismus, refractive errors | 35-60% | Ophthalmology by 6 months, then annually |
| MSK | Atlantoaxial instability | 10-30% radiographic | C-spine films ages 3-5 |
| Sleep | OSA | 50-75% | PSG by age 4 |
Cardiac
Congenital heart disease occurs in 40-50% of individuals; atrioventricular septal defect (AVSD) is the most common. Echocardiogram recommended for all newborns with Down syndrome regardless of auscultatory findings. Surgical repair is typically performed within the first 6 months to prevent pulmonary hypertension.
Endocrine
Hypothyroidism occurs in 15-20%; TSH screening at birth, 6 months, 12 months, then annually. Increased risk of type 1 diabetes and celiac disease with shared autoimmune predisposition. Screening for celiac disease with tissue transglutaminase IgA recommended starting at age 2.
Hematologic
Transient abnormal myelopoiesis (TAM) occurs in ~10% of neonates and usually resolves spontaneously. Children with prior TAM have a 20-30% risk of developing acute megakaryoblastic leukemia (AMKL) by age 4. CBC monitoring is recommended in the first 3 years of life.
Sensory and Developmental
Hearing loss (conductive and sensorineural) affects up to 75%; audiologic evaluation by 6 months and annually. Ophthalmologic conditions include strabismus, nystagmus, nasolacrimal duct obstruction, and refractive errors. Early intervention services and individualized education programs (IEPs) are essential. Atlantoaxial instability: Cervical spine radiographs between ages 3-5, particularly before participation in contact sports.
Health Supervision in Adolescence and Adulthood
Obesity and Metabolic Health
Obesity prevalence is significantly higher; lower basal metabolic rate contributes. Continued annual thyroid screening throughout life. Screen for obstructive sleep apnea (OSA) which affects 50-75% of individuals; polysomnography recommended by age 4 and repeated as clinically indicated. Encourage physical activity and healthy dietary habits with accessible programming.
Mental Health and Neurodevelopment
Depression and anxiety are common but may be underdiagnosed due to communication challenges. Behavioral changes should prompt evaluation for medical causes (pain, hypothyroidism, OSA) Early-onset Alzheimer disease: Virtually all adults with Down syndrome develop neuropathology by age 40; clinical dementia affects approximately 50% by age 60. Baseline cognitive assessment in early adulthood aids detection of subsequent decline. Emerging treatments for Alzheimer disease in this population are under active investigation.
Reproductive and Sexual Health
Females are usually fertile; males are typically infertile. Contraception counseling and gynecologic care should follow standard guidelines with accommodations. Pregnancy in women with Down syndrome carries a 50% risk of trisomy 21 in offspring.
Musculoskeletal
Ongoing monitoring for atlantoaxial instability with symptomatic screening. Higher rates of hip instability, patellar subluxation, and pes planus. Osteoporosis screening considerations in adults.
Transition and Adult Care
Structured healthcare transition should begin at age 12-14 with increasing patient involvement. Establish guardianship or supported decision-making before age 18 when appropriate. Adult care providers should be familiar with AAP/Global Down Syndrome Foundation health supervision guidelines. Facilitate community integration, supported employment, and independent living skills. Life expectancy has increased dramatically; care must address aging-related conditions alongside Down syndrome-specific concerns.
Clinical Pearls
All newborns with Down syndrome need an echocardiogram regardless of examination findings due to the high prevalence of congenital heart disease. Annual thyroid screening is lifelong; hypothyroidism may present subtly and overlap with baseline features. Obstructive sleep apnea is vastly underdiagnosed and contributes to behavioral issues, cognitive decline, and pulmonary hypertension. Baseline cognitive testing in early adulthood is critical for later detection of Alzheimer disease-related decline. Atlantoaxial instability screening should occur before surgical procedures requiring neck positioning and before high-risk sports participation.
References
- Bull MJ, Trotter T, Santoro SL, et al. Health supervision for children and adolescents with Down syndrome. Pediatrics. 2022;149(5):e2022057010.
- Tsou AY, Bulova P, Capone G, et al. Medical care of adults with Down syndrome: A clinical guideline. JAMA. 2020;324(15):1543-1556.
- Fortea J, Vilaplana E, Carmona-Iragui M, et al. Clinical and biomarker changes of Alzheimer disease in adults with Down syndrome. JAMA Neurol. 2020;77(7):823-830.
- Santoro SL, Steffensen EH. Global Down Syndrome Foundation medical care guidelines for adults with Down syndrome. J Clin Med. 2022;11(4):1012.